Name | cay10526 |
---|---|
Synonyms |
4-benzo(b)thiophen-2-yl-3-bromo-5-hydroxy-5H-furan-2-one
4-(1-Benzothiophen-2-yl)-3-bromo-5-hydroxy-2(5H)-furanone 2(5H)-Furanone, 4-benzo[b]thien-2-yl-3-bromo-5-hydroxy- 4-(1-benzothiophen-2-yl)-3-bromo-5-hydroxyfuran-2(5H)-one |
Description | CAY10526 is a specific microsomal PGE2 synthase-1 (mPGES1) inhibitor. CAY10526 inhibits PGE2 production through the selective modulation of mPGES1 expression but does not affect COX-2. CAY10526 significantly suppresses tumor growth and increases apoptosis in melanoma xenografts. CAY10526 reduces BCL-2 and BCL-XL (anti-apoptotic) protein levels and increases BAX and BAK (pro-apoptotic) as well as cleaved caspase 3 levels. CAY10526 inhibits cell viability (IC50<5 μM) in three melanoma cell lines expressing mPGES1[1]. |
---|---|
Related Catalog | |
References |
Density | 1.9±0.1 g/cm3 |
---|---|
Boiling Point | 561.7±50.0 °C at 760 mmHg |
Molecular Formula | C12H7BrO3S |
Molecular Weight | 311.151 |
Flash Point | 293.5±30.1 °C |
Exact Mass | 309.929932 |
PSA | 74.77000 |
LogP | 2.54 |
Vapour Pressure | 0.0±1.6 mmHg at 25°C |
Index of Refraction | 1.791 |